rs185386680
From SNPedia
Orientation | plus |
Stabilized | plus |
Geno | Mag | Summary |
---|---|---|
(A;A) | 0 | common/normal |
(A;G) | 2.2 | carrier of one HLA-B*38:02:01 allele; avoid thioamide drugs |
Make rs185386680(G;G) |
Reference | GRCh38.p2 38.2/146 |
Chromosome | 6 |
Position | 31207153 |
is a | snp |
is | mentioned by |
dbSNP | rs185386680 |
dbSNP (classic) | rs185386680 |
ClinGen | rs185386680 |
ebi | rs185386680 |
HLI | rs185386680 |
Exac | rs185386680 |
Gnomad | rs185386680 |
Varsome | rs185386680 |
LitVar | rs185386680 |
Map | rs185386680 |
PheGenI | rs185386680 |
Biobank | rs185386680 |
1000 genomes | rs185386680 |
hgdp | rs185386680 |
ensembl | rs185386680 |
geneview | rs185386680 |
scholar | rs185386680 |
rs185386680 | |
pharmgkb | rs185386680 |
gwascentral | rs185386680 |
openSNP | rs185386680 |
23andMe | rs185386680 |
SNPshot | rs185386680 |
SNPdbe | rs185386680 |
MSV3d | rs185386680 |
GWAS Ctlg | rs185386680 |
Max Magnitude | 2.2 |
rs185386680(G) appears to be in complete linkage disequilibrium with the HLA-B*38:02:01 allele, and can therefore be used as a marker for it.[PMID 26599303]
The HLA-B*38:02:01 allele is associated with carbimazole/methimazole-induced agranulocytosis (OR=265.5, CI: 27.9-2528, p=2.5x10-e14), but not associated with propylthiouracil, so screening for the risk allele may be useful in preventing agranulocytosis in hyperthyroid patients potentially being treated with thioamides antithyroid-drugs, such as thioacetamide, methimazole, or carbimazole.[PMID 26599303]